FDA Inspection
Janssen Biotech, Inc.Janssen Biotech, Inc. – FDA Inspection, Jul 29, 2025
Record Details
This FDA Inspection record concerns Janssen Biotech, Inc., with an inspection on July 29, 2025, issued by the Philadelphia District Office, covering human drugs.
View Company Profile
ID · 0ecc31ca-e799-4909-bfc9-dcdfa484fbf5
Inspection Facts
- Inspection number
- 1276933
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Janssen Biotech, Inc.
14| Date | Classification | Office | Project area |
|---|---|---|---|
| March 10, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 30, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 5, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 22, 2017 | Not classified | Philadelphia District Office |
Other documents for Janssen Biotech, Inc.
- FDA Inspection 1265723 - 2025-03-10
- FDA Inspection 1077487 - 2018-11-30
- FDA Inspection 1046499 - 2018-03-05
- FDA Inspection 1031776 - 2017-11-21
- FDA Inspection 1027122 - 2017-09-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.